Legato Capital Management’s Chemed CHE Stock Holding History

Legato Capital Management’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,615	Closed	-$691K	–	759
2025 Q4	$691K	Buy	+1,615	New	+$703K	0.06%	461

Other funds holding CHE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Legato Capital Management's CHE Position: Q1 2026 in Review

Legato Capital Management sold out of Chemed (CHE) in Q1 2026, closing a stake of 1,615 shares — an estimated $691K sold.

Legato Capital Management first reported a position in CHE in Q4 2025 and held it in 1 quarter. The position peaked at $691K in Q4 2025. 489 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

Legato Capital Management reported no remaining Chemed position as of Q1 2026 after selling out during the quarter.
Legato Capital Management sold 1,615 Chemed shares in Q1 2026, an estimated $691K.
Legato Capital Management first reported a position in Chemed in Q4 2025 and held it in 1 quarter.
Legato Capital Management's Chemed position peaked at $691K in Q4 2025.
489 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.